Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Combination therapies on osteoporosis].

Toshiyuki Horiuchi1

  • 1Tokyo Metropolitan Geriatric Hospital.

Clinical Calcium
|March 19, 2005
PubMed
Summary

Combination therapies using bisphosphonates with conjugated equine estrogen (CEE) or vitamin D effectively increase bone mineral density (BMD) in osteoporotics. These combinations also reduce vertebral fractures, offering broader benefits than monotherapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substrate and laser power dependence of surface-enhanced Raman scattering from a silver oxide film.

Nanotechnology·2015
Same author

Effect of Ezetimibe on LDL-C Lowering and Atherogenic Lipoprotein Profiles in Type 2 Diabetic Patients Poorly Controlled by Statins.

PloS one·2015
Same author

Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects.

SpringerPlus·2013
Same author

Isolated adrenocorticotropin deficiency associated with delirium and takotsubo cardiomyopathy.

Case reports in endocrinology·2012
Same author

Association of CYP19 gene polymorphism with vertebral fractures in Japanese postmenopausal women.

Biochemical genetics·2011
Same author

[Parathyroid].

Nihon rinsho. Japanese journal of clinical medicine·2011

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Pharmacology

Context:

  • Osteoporosis management often involves bisphosphonate monotherapy.
  • Limited efficacy of bisphosphonate monotherapy in improving bone mineral density (BMD) at all skeletal sites.
  • Need for combination therapies to enhance treatment outcomes in osteoporosis.

Purpose:

  • To evaluate the efficacy of combination therapies involving bisphosphonates with conjugated equine estrogen (CEE), vitamin D, or parathyroid hormone (PTH) in osteoporotic patients.
  • To compare the effects of these combination therapies on lumbar bone mineral density (LBMD) and femoral neck bone mineral density (FBMD).
  • To assess the impact on fracture reduction and identify potential interactions between agents.

Summary:

  • Combination therapy of bisphosphonates with CEE demonstrated significant increases in LBMD and FBMD in elderly osteoporotic patients.
  • Bisphosphonate and vitamin D combination therapy also showed advantages in increasing LBMD and FBMD, with vitamin D potentially aiding non-responders.
  • Combination therapy with PTH may complicate or reduce the efficacy of alendronate, suggesting careful consideration.

Impact:

  • Combination therapies, particularly with CEE and vitamin D, offer superior BMD improvements at both lumbar and femoral sites compared to bisphosphonate monotherapy.
  • These combined approaches may lead to a reduction in new vertebral fractures in osteoporotic individuals.
  • The findings highlight the potential for tailored combination strategies to optimize osteoporosis treatment, while cautioning against certain combinations like bisphosphonate with PTH.

Related Experiment Videos